Atara Biotherapeutics's total assets for Q4 2024 were $109.10M, a decrease of -23.55% from the previous quarter. ATRA total liabilities were $206.38M for the fiscal quarter, a -11.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.